Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 28, 2023; 29(4): 706-730
Published online Jan 28, 2023. doi: 10.3748/wjg.v29.i4.706
Published online Jan 28, 2023. doi: 10.3748/wjg.v29.i4.706
Age median (quartile) | P value | Male, n (%) | Female, n (%) | P value | |
Gastric cancer | 61 (51, 68) | < 0.001 | 268 (68.4) | 124 (31.6) | 0.084 |
Non-gastric cancer | 48 (42, 56) | 20831 (64.2) | 11634 (35.8) | ||
Colorectal cancer | 62 (55, 70) | < 0.001 | 522 (58.5) | 370 (41.5) | < 0.001 |
Non-colorectal cancer | 48 (42, 55) | 20577 (64.4) | 11388 (35.6) | ||
Gastrointestinal cancer | 62 (53, 69) | < 0.001 | 816 (62.4) | 491 (37.6) | 0.170 |
Non-gastrointestinal cancer | 48 (42, 55) | 20283 (64.3) | 11267 (35.7) |
- Citation: Liu HN, Yao C, Wang XF, Zhang NP, Chen YJ, Pan D, Zhao GP, Shen XZ, Wu H, Liu TT. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers. World J Gastroenterol 2023; 29(4): 706-730
- URL: https://www.wjgnet.com/1007-9327/full/v29/i4/706.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i4.706